Cargando…

A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central nervous system (CNS) leading to mental deterioration and devastation, and eventually a fatal outcome. AD affects mostly the elderly. AD is frequently accompanied by hypercholesterolemia, hypertension, atheroscle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maciejewska, Karolina, Czarnecka, Kamila, Szymański, Paweł
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599320/ https://www.ncbi.nlm.nih.gov/pubmed/34121170 http://dx.doi.org/10.1007/s43440-021-00293-5

Ejemplares similares

Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
por: Maciejewska, Karolina, et al.
Publicado: (2022)

New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2017)

Memantine in neurological disorders – schizophrenia and depression
por: Czarnecka, Kamila, et al.
Publicado: (2021)

Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2019)

New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer’s Disease Research
por: Koźmiński, Przemysław, et al.
Publicado: (2022)

Aspartame—True or False? Narrative Review of Safety Analysis of General Use in Products
por: Czarnecka, Kamila, et al.
Publicado: (2021)

Activity of Selected Group of Monoterpenes in Alzheimer’s Disease Symptoms in Experimental Model Studies—A Non-Systematic Review
por: Wojtunik-Kulesza, Karolina, et al.
Publicado: (2021)

New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2020)

Radiolabeled Peptides and Antibodies in Medicine
por: Kręcisz, Paweł, et al.
Publicado: (2020)

New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2023)

Towards a Consensus on Alzheimer’s Disease Comorbidity?
por: Avitan, Iska, et al.
Publicado: (2021)

Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs—Updated Review
por: Mruk-Mazurkiewicz, Honorata, et al.
Publicado: (2023)

Biological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal model
por: Kłosiński, Karol, et al.
Publicado: (2020)

Function and Comorbidities of Apolipoprotein E in Alzheimer's Disease
por: Leduc, Valérie, et al.
Publicado: (2011)

Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
por: Newcombe, Estella A., et al.
Publicado: (2018)

Selected Natural Products in Neuroprotective Strategies for Alzheimer’s Disease—A Non-Systematic Review
por: Wojtunik-Kulesza, Karolina, et al.
Publicado: (2022)

Characterization of Metal-Bound Benzimidazole Derivatives, Effects on Tumor Cells of Lung Cancer
por: Raducka, Anita, et al.
Publicado: (2021)

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
por: Guo, Tiantian, et al.
Publicado: (2020)

rTMS as a Treatment of Alzheimer's Disease with and without Comorbidity of Depression: A Review
por: Rutherford, Grant, et al.
Publicado: (2013)

Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms
por: Ma, Yue, et al.
Publicado: (2023)

The Impact of Disease Comorbidities in Alzheimer's Disease
por: Santiago, Jose A., et al.
Publicado: (2021)

Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
por: Mizuki, Yutaka, et al.
Publicado: (2020)

Biological Evaluation, Molecular Docking, and SAR Studies of Novel 2-(2,4-Dihydroxyphenyl)-1H- Benzimidazole Analogues
por: Matysiak, Joanna, et al.
Publicado: (2019)

Somatic comorbidities and Alzheimer’s disease treatment
por: Clodomiro, Alessandra, et al.
Publicado: (2013)

Cytotoxic Activity against A549 Human Lung Cancer Cells and ADMET Analysis of New Pyrazole Derivatives
por: Czylkowska, Agnieszka, et al.
Publicado: (2021)

Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms
por: Hwang, Kaylin, et al.
Publicado: (2022)

An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease
por: Ratan, Yashumati, et al.
Publicado: (2023)

Comorbidity and progression of late onset Alzheimer’s disease: A systematic review
por: Haaksma, Miriam L., et al.
Publicado: (2017)

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer's Disease
por: Govindarajulu, Manoj, et al.
Publicado: (2018)

A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder
por: Guo, Pan, et al.
Publicado: (2022)

Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
por: Femminella, Grazia Daniela, et al.
Publicado: (2018)

Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
por: Afsar, Atefeh, et al.
Publicado: (2023)

Alzheimer’s disease and epilepsy: An increasingly recognized comorbidity
por: Yang, Fei, et al.
Publicado: (2022)

Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease: a systematic review of symptom-general and –specific lesion patterns
por: Chen, Yaojing, et al.
Publicado: (2021)

Why Is Iron Deficiency/Anemia Linked to Alzheimer’s Disease and Its Comorbidities, and How Is It Prevented?
por: Fehsel, Karin
Publicado: (2023)

Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
por: Kryczka, Jolanta, et al.
Publicado: (2021)

Clinical significance of microbiota changes under the influence of psychotropic drugs. An updated narrative review
por: Misera, Agata, et al.
Publicado: (2023)

Psychogenic non-epileptic seizures: so-called psychiatric comorbidity and underlying defense mechanisms
por: Beghi, Massimiliano, et al.
Publicado: (2015)

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases
por: Bharadwaj, P R, et al.
Publicado: (2013)

Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer’s Disease Neuropathology
por: Kok, Frédérique K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nk485edvsc96u1eopo49hg8vhi